Three genes (APOB, PPAT, and TRPV1) were associated with both DFS and OS of HCC, suggesting that APOB, PPAT, and TRPV1 may be significant and effective in predicting both the progress and the adverse outcomes of HCC. This evidence concerns the gene PPAT and hepatocellular carcinoma.